HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Selective bone marrow involvement of lymphoplasmacytic cells secreting monoclonal IgA rheumatoid factor in a patient with Sjögren's syndrome and serum hyperviscosity.

Abstract
The clinical features and results of serological studies of a patient with Sjögren's syndrome, IgA kappa monoclonal gammopathy, and hyperviscosity syndrome are reported. The novel aspect of this case is the selective localisation to the bone marrow of lymphoplasmacytoid cells secreting IgA kappa morphologically identical to the cells infiltrating the salivary glands. The serum of the patient contained large amounts of immunoglobulin-anti-immunoglobulin immune complexes. By gel filtration chromatography it was shown that the immune complexes formed a peak of molecular weight 680 kilodaltons. The immune complexes were dissociable under acidic conditions. The immunoglobulin with rheumatoid activity was characterised as monoclonal IgA kappa protein. Treatment with plasmapheresis combined with immunosuppressive treatment with cyclophosphamide reduced the serum viscosity with concomitant clinical improvement.
AuthorsC Bergonzi, G P Merlini, S Morandi, E Bianchini, F Pavesi, V Bellotti, C M Montecucco, E Ascari
JournalAnnals of the rheumatic diseases (Ann Rheum Dis) Vol. 46 Issue 12 Pg. 938-42 (Dec 1987) ISSN: 0003-4967 [Print] England
PMID3426303 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Immunoglobulin A
  • Rheumatoid Factor
Topics
  • Blood Viscosity
  • Bone Marrow Cells
  • Female
  • Humans
  • Immunoglobulin A (metabolism)
  • Lymphocytes (immunology)
  • Middle Aged
  • Monoclonal Gammopathy of Undetermined Significance (complications)
  • Plasma Cells (immunology)
  • Rheumatoid Factor (metabolism)
  • Sjogren's Syndrome (blood, complications, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: